AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
GeoVax Labs Statistics
Share Statistics
GeoVax Labs has 159.53M shares outstanding. The number of shares has increased by 41.02% in one year.
Shares Outstanding | 159.53M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 28.76% |
Owned by Institutions (%) | n/a |
Shares Floating | 164.99M |
Failed to Deliver (FTD) Shares | - |
FTD / Avg. Volume | -% |
Short Selling Information
The latest short interest is 0, so 0% of the outstanding shares have been sold short.
Short Interest | 0 |
Short % of Shares Out | 0% |
Short % of Float | 0% |
Short Ratio (days to cover) | 0 |
Valuation Ratios
The PE ratio is -0.53 and the forward PE ratio is null.
PE Ratio | -0.53 |
Forward PE | null |
PS Ratio | 0 |
Forward PS | null |
PB Ratio | 2.39 |
P/FCF Ratio | -0.55 |
PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for GeoVax Labs Inc..
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.24, with a Debt / Equity ratio of 0.
Current Ratio | 2.24 |
Quick Ratio | 2.24 |
Debt / Equity | 0 |
Total Debt / Capitalization | 0 |
Cash Flow / Debt | 0 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -4.51% and return on capital (ROIC) is -464.02%.
Return on Equity (ROE) | -4.51% |
Return on Assets (ROA) | -2.8% |
Return on Capital (ROIC) | -464.02% |
Revenue Per Employee | 0 |
Profits Per Employee | -1.53M |
Employee Count | 17 |
Asset Turnover | 0 |
Inventory Turnover | 0 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 3.11, so GeoVax Labs 's price volatility has been higher than the market average.
Beta | 3.11 |
52-Week Price Change | null% |
50-Day Moving Average | 0.12 |
200-Day Moving Average | 0.12 |
Relative Strength Index (RSI) | 49.25 |
Average Volume (20 Days) | - |
Income Statement
Revenue | n/a |
Gross Profit | -20.72M |
Operating Income | -26.74M |
Net Income | -25.97M |
EBITDA | -26.67M |
EBIT | n/a |
Earnings Per Share (EPS) | -10.22 |
Balance Sheet
The company has 6.45M in cash and 0 in debt, giving a net cash position of 6.45M.
Cash & Cash Equivalents | 6.45M |
Total Debt | 0 |
Net Cash | 6.45M |
Retained Earnings | -104.36M |
Total Assets | 11.11M |
Working Capital | 8.26M |
Cash Flow
In the last 12 months, operating cash flow was -25.17M and capital expenditures -48.95K, giving a free cash flow of -25.22M.
Operating Cash Flow | -25.17M |
Capital Expenditures | -48.95K |
Free Cash Flow | -25.22M |
FCF Per Share | -9.93 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
GOVXW does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for GOVXW.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | -17.27 |
Piotroski F-Score | 3 |